Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 22% ± 8% | |
epithelial cell | 6 studies | 30% ± 10% | |
plasmacytoid dendritic cell | 4 studies | 22% ± 4% | |
B cell | 3 studies | 21% ± 4% | |
non-classical monocyte | 3 studies | 20% ± 5% | |
smooth muscle cell | 3 studies | 22% ± 7% | |
ciliated cell | 3 studies | 25% ± 3% | |
dendritic cell | 3 studies | 32% ± 8% | |
natural killer cell | 3 studies | 18% ± 2% | |
basal cell | 3 studies | 30% ± 8% | |
oligodendrocyte | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2638.71 | 21 / 21 | 100% | 26.95 | 504 / 504 |
breast | 100% | 2713.69 | 459 / 459 | 100% | 28.11 | 1118 / 1118 |
esophagus | 100% | 2455.98 | 1445 / 1445 | 100% | 23.15 | 183 / 183 |
intestine | 100% | 2914.21 | 966 / 966 | 100% | 31.12 | 527 / 527 |
liver | 100% | 1289.16 | 226 / 226 | 100% | 17.48 | 406 / 406 |
lung | 100% | 1868.44 | 578 / 578 | 100% | 22.69 | 1155 / 1155 |
ovary | 100% | 2169.71 | 180 / 180 | 100% | 21.78 | 430 / 430 |
pancreas | 100% | 1677.88 | 328 / 328 | 100% | 19.86 | 178 / 178 |
prostate | 100% | 2933.09 | 245 / 245 | 100% | 34.44 | 502 / 502 |
stomach | 100% | 2163.78 | 359 / 359 | 100% | 31.71 | 286 / 286 |
thymus | 100% | 2513.10 | 653 / 653 | 100% | 23.73 | 605 / 605 |
uterus | 100% | 2485.43 | 170 / 170 | 100% | 28.02 | 459 / 459 |
adrenal gland | 100% | 1629.35 | 258 / 258 | 99% | 16.29 | 228 / 230 |
kidney | 100% | 1369.49 | 89 / 89 | 99% | 13.41 | 891 / 901 |
brain | 98% | 916.57 | 2592 / 2642 | 100% | 17.59 | 705 / 705 |
skin | 100% | 1819.15 | 1809 / 1809 | 94% | 13.57 | 443 / 472 |
adipose | 100% | 2222.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 32.01 | 29 / 29 |
spleen | 100% | 2557.57 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.29 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.07 | 1 / 1 |
blood vessel | 100% | 1926.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1138.74 | 852 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 962.87 | 780 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 9.02 | 61 / 80 |
peripheral blood | 63% | 762.09 | 587 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0006974 | Biological process | DNA damage response |
GO_0016925 | Biological process | protein sumoylation |
GO_0006281 | Biological process | DNA repair |
GO_0032204 | Biological process | regulation of telomere maintenance |
GO_0140588 | Biological process | chromatin looping |
GO_0030915 | Cellular component | Smc5-Smc6 complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | NSMCE4A |
Protein name | Non-structural maintenance of chromosomes element 4 homolog A (NS4EA) (Non-SMC element 4 homolog A) |
Synonyms | C10orf86 PP4762 |
Description | FUNCTION: Component of the SMC5-SMC6 complex, a complex involved in DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). Is involved in positive regulation of response to DNA damage stimulus. . |
Accessions | Q9NXX6 ENST00000369017.5 [Q9NXX6-2] ENST00000369023.8 [Q9NXX6-1] |